News Focus
News Focus
Followers 122
Posts 3407
Boards Moderated 0
Alias Born 06/28/2014

Re: north40000 post# 211985

Friday, 08/30/2019 5:08:10 PM

Friday, August 30, 2019 5:08:10 PM

Post# of 448124
To be a successful investor one needs to be AHEAD of the CURVE AND still in that upcoming environment still be ON the rails!

The above takes many skillsets and few can grapple with in a lifetime given the ultra dynamics of the world we live in: ie Global Warming/Climate Change
Re Crop Yields; Islands disappearing; cities/homes under water etc etc.

Specifically it all relates to understanding how each investment may avoid the above potential exposureS and how each is strategically positioned to withstand the impending onslaughts. Some may need a back up plan. Clearly that’s what supposedly why CEO’s get paid multiple scores above average Corp employees!

Taking BOTH a bottom’s up analysis as well as a top down analysis is the optimal

One clearly needs to understand as it relates to ANY company one cited:

Will they be #1 or # 2 in their respective fields and IF they are not currently what do they need to get to topple those incumbents?

Will consumers still be buying in that environment?

Is the technology far superior?

Where are each company in terms of the products life cycle: I stated two years ago in many posts the
Saturation of Smartphones and Apple’s tough slough in China

LOTS of spadework

Fortunately AMRN’s Vascepa is well positioned as there is an INELASTIC demand for their proprietary compound which I discovered on my own four years ago in surfing thru for the first and only time the FDA’s database that convinced me that Vascepa is a NCE: more than doubled up at ~$1!

DIFFERENT STROKES FOR DIFFERENT FOLKS


















DIFFERENT STROKES FOR DIFFERENT FOLKS

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News